Recommendations for the Long-Term Treatment of Psoriasis with Infliximab: A Dermatology Expert Group Consensus

Publisher： Karger

E-ISSN： 1421-9832|217|3|268-275

ISSN： 1018-8665

Source： Dermatology, Vol.217, Iss.3, 2008-08, pp. : 268-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab

By  

Dermatology, Vol. 221, Iss. 1, 2010-08 ,pp. : 43-47

Karger

Access to resources Recommend Favorite

Long-Term Treatment with Fumaric Acid Esters in an 11-Year-Old Male Child with Psoriasis

By  

Dermatology, Vol. 222, Iss. 3, 2011-04 ,pp. : 198-200

Karger

Access to resources Recommend Favorite

Tacalcitol Ointment for Long-Term Control of Chronic Plaque Psoriasis in Dermatological Practice

By  

Dermatology, Vol. 204, Iss. 4, 2002-06 ,pp. : 321-324

Karger

Access to resources Recommend Favorite

Successful Treatment of Recalcitrant Palmoplantar Pustular Psoriasis with Sequential Use of Infliximab and Adalimumab

By  

Dermatology, Vol. 218, Iss. 1, 2008-10 ,pp. : 79-83

Karger

Access to resources Recommend Favorite

Response of Severe Psoriasis to Infliximab

By  

Dermatology, Vol. 204, Iss. 2, 2002-04 ,pp. : 156-157

Karger

Access to resources Recommend Favorite